Precision Vaccinations

 / February 24th, 2021

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Feb 24 • 10:19 am CST
New Jersey-based Quest Diagnostics introduced a new COVID-19 testing service on February 24, 2021, that aids in providing insight into an individual's immune response as a result of a recent or prior infection with SARS-CoV-2 or... READ →
Feb 24 • 7:40 am CST
The U.S. FDA's Vaccines and Related Biological Products Advisory Committee posted the JANSSEN BIOTECH, INC ., Sponsor Briefing Document Addendum on February 24, 2021, for COVID-19 Vaccine Ad26.COV2.S VAC31518 (JNJ-78436735) meeting scheduled for February 26, 2021... READ →
Feb 24 • 6:53 am CST
Takeda Pharmaceutical Company Limited announced today that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax’ COVID-19 vaccine candidate (TAK-019) in Japan. The results from the TAK-019 study are expected... READ →
Feb 23 • 9:20 pm CST
New York-based Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application for TicoVac™, its tick-borne encephalitis (TBE) vaccine for active immunization to prevent TBE in... READ →
Feb 23 • 7:00 pm CST
The U.S. Food and Drug Administration issued new guidance for medical product developers, specifically covering vaccines, diagnostics, and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2, the coronavirus that causes... READ →

For more articles, try our search.